A Unique Roadblock for Pfizer’s Osteoarthritis Drug
We’ve heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?
winston laboratories
MediciNova to Buy Avigen for $37 Million
Pharmaceutical company MediciNova announced that it will buy Avigen (AVGN) for $1.24 per share, approximately $37 million.
FDA Approves Kowa’s Cambia for Migraines
In clinical trials, Cambia provided statistically significant onset of relief of migraine pain within 15 to 30 minutes.